Do you want to know more about Parkinson's? PDF's materials provide information about symptoms, medications, resources & more.
Medication Side Effects
Originally presented on April 8, 2014
Hubert H. Fernandez, M.D., Cleveland Clinic Lerner College of Medicine
Over time, many people with Parkinson's will experience side effects of medications used to treat the disease, particularly as new medications are added or doses of existing medications are increased. Find out more about common side effects of Parkinson's medications, such as dyskinesia, wearing-off, drowsiness, sleep attacks, hallucinations and impulse control disorders. Find practical strategies for managing them.
Goals for Participants
- Be aware of the available medications for early, moderate and advanced Parkinson's disease.
- Understand what these medications can and cannot do for Parkinson's symptoms.
- Know the potential side effects of medications, and which ones require more vigilant monitoring.
- Be familiar with strategies for coping with these side effects when they do occur.
Hubert H. Fernandez, M.D.
Hubert H. Fernandez, M.D., is Professor of Medicine (Neurology) at the Cleveland Clinic Lerner College of Medicine, Case Western Reserve University and the Head of Movement Disorders under the Center for Neurological Restoration at Cleveland Clinic in Cleveland, OH.
Dr. Fernandez is an internationally recognized expert in movement disorders. After completing his medical training, he joined the faculty of Brown University School of Medicine as Assistant Professor of the Department of Clinical Neurosciences and served as Associate Director of the Movement Disorders Unit and Neurological Director of its Functional Neurosurgical Program. In 2003, Dr. Fernandez relocated to the University of Florida, where he eventually became Director of the Clinical Research Unit for Neurological and Psychiatric Disorders, Vice Chair of Academic Affairs, and Professor of Neurology prior to joining Cleveland Clinic.
An active and productive researcher, he has initiated or participated in over 50 clinical trials and has published his findings in well over 300 articles and abstracts on Parkinson’s disease, cervical dystonia, blepharospasm, and other movement disorders. He has nearly 40 published book chapters and books to his credit, and has served on the editorial board of Movement Disorders and is currently an editorial board member of the American Journal of Clinical Neurology, European Neurological Journal, and Clinical Neuropharmacology.
Dr. Fernandez is a fellow of the American Academy of Neurology, and a member of the American Neurological Association. He is currently elected as a Councilor for the AAN Movement Disorders Section, Executive Committee Member of the Parkinson Study Group and Dystonia Study Group; and is also an Executive Board Member of the World Neurology Foundation. He has served as President of the Florida Society of Neurology, and is the current Co-Medical Editor of the website of the International Parkinson and Movement Disorder Society. Recently, he has been elected the Co-Chair of the Parkinson Study Group for a six year term.
Dr. Fernandez received both his B.S. in Biology and M.D. in the Philippines. He completed his internship in internal medicine at University of Pennsylvania/Pennsylvania Hospital in Philadelphia, Pennsylvania; his residency in neurology at Boston University Medical Center in Massachusetts; and his fellowship in movement disorders at Brown University in Rhode Island.
If you have questions about how to join this PD ExpertBriefing, by phone or online, please see our PD ExpertBriefing FAQ.
Are you a health care professional seeking continuing education units? CEUs are provided via PDF's sponsorship of the American Society on Aging. The CEU deadline for this online seminar has now passed. Please check our schedule of future seminars for opportunities to obtain continuing education credits.
Browse our library of past seminars and watch them at any time to learn more about nutrition, the PD pipeline and other topics.
This series has been made possible by educational grants from AbbVie, Inc. and Teva Neuroscience.